Purpose: MHC class I presentation of peptides allows T cells to survey the cytoplasmic protein milieu of host cells. During infection, presentation of self peptides is, in part, replaced by presentation of microbial peptides. However, little is known about the self peptides presented during infection, despite the fact that microbial infections alter host cell gene expression patterns and protein metabolism. Experimental design: The self peptide repertoire presented by HLA-A*01;01, HLA-A*02;01, HLA-B*07;02, HLA-B*35;01, and HLA-B*45;01 (where HLA is human leukocyte antigen) was determined by tandem MS before and after vaccinia virus infection. Results: We observed a profound alteration in the self peptide repertoire with hundreds of self peptides uniquely presented after infection for which we have coined the term "self peptidome shift." The fraction of novel self peptides presented following infection varied for different HLA class I molecules. A large part (approximately 40%) of the self peptidome shift arose from peptides derived from type I interferon-inducible genes, consistent with cellular responses to viral infection. Interestingly, approximately 12% of self peptides presented after infection showed allelic variation when searched against approximately 300 human genomes. Conclusion and clinical relevance: Self peptidome shift in a clinical transplant setting could result in alloreactivity by presenting new self peptides in the context of infection-induced inflammation.
Introduction
MHC class I restricted antigen processing and presentation inform T cells as to the internal state of the cell by binding cytoplasmic peptides and presenting them at the cell surface [1] [2] [3] . Under homeostatic conditions, these peptides are derived from self proteins and their presentation signifies normal cellular operations and as such is ignored by
Clinical Relevance
MHC-encoded class I molecules present peptides derived from cellular proteins to CD8, informing them of a cell's milieu intérieur (cellular homeostasis). Cellular homeostasis is altered under a variety of stressed conditions, including during microbial infections. While there were hints that infected cells altered the presentation of self peptide repertoire, this notion was not fully explored. Herein, through mass spectrometric analysis of thousands of self peptides isolated from HLA class I molecules (the largest study of its kind to date), we observed a dramatic shift in the self peptide repertoires presented after infection of HeLa cells with VACV. Of significant clinical importance was the revelation that a fraction of the self peptides were derived from tumor-specific antigens. Furthermore, the self peptides uniquely presented after infection contained variants of such peptides-called allopeptides-within the human population. Approximately 12% of the self peptides uniquely presented after infection were potential allopeptides, the recognition of which can result in GVHD or transplant rejection. The proportion of allopeptides was very similar to the reported rate of transplant complication and failure (approximately 10%). Our study suggests that deep sequencing and proteomics analyses of self peptides may enhance the success of clinical transplant outcome and tumor immunotherapies.
self-educated T cells. During an infection however, microbial peptides are processed and fed into this antigen presentation pathway alerting the immune system to the presence of a pathogen [4] . Activation of an innate immune response to the pathogen creates an inflammatory milieu that provides additional signals to the T cell, triggering its full activation.
Self peptide presentation at the immunological synapse contributes to T-cell activation by lowering the activation threshold [5] [6] [7] . Since self peptides are continuously present at the immunological synapse, T cells strongly recognizing self peptide/MHC complexes (pMHC) must be deleted during thymic education to prevent the development of autoimmune disease [8] . However, T-cell positive selection requires weak recognition of self pMHC complexes [9] . Peripheral self pMHC recognition in the absence of inflammation leads to tolerization [10] . Conversely, self peptide recognition in the context of the inflammatory stimulus emerging from a microbial infection can lead to activation of weakly self-reactive T cells and the development of autoimmune disease, for example, diabetes, multiple sclerosis, and polymyositis [11, 12] . Therefore, optimal peripheral T-cell activation requires a combination of inflammatory signals, nonself pMHC recognition, and low affinity self pMHC recognition to fully activate T cells.
Even though T cells strongly reactive to self pMHC are deleted during development, self peptides can act as minor histocompatibility antigens in the context of allograft transplantation if the genes encoding self peptides show allelic variation (i.e., when DNA sequences for the same gene differ between two or more individuals) within the human population [13] [14] [15] [16] . Presentation of peptides containing allelic differences, termed allopeptides, by the human leukocyte antigen (HLA) of donor-transplanted tissue cells can activate recipient T cells, leading to graft rejection. Alternatively, donor T cells may recognize recipient allopeptides, leading to graft versus host disease (GVHD) even in a HLA-matched bone marrow transplant. Since immunosuppressive drugs given to the otherwise healthy transplant recipient suppress inflammation, allopeptide recognition by T cells should lead to tolerance. Nonetheless, once the graft has been accepted and the immunosuppressive drugs are withdrawn, subsequent infections would incite inflammatory conditions. Indeed, viral infections occur after transplantation in approximately 10-60% of immunosuppressed patients, leading to adverse effects on the host and/or transplanted organ [17, 18] . Recognition of new allopeptides that T cells have not been tolerized against, for example, those that are not presented during homeostatic conditions, could result in T-cell activation and immunopathology [19] . Hence, alterations in self peptides under inflammatory conditions can be detrimental to transplanted tissues/organs.
Despite their importance, little is known regarding the nature of the self peptide repertoire (peptidome) displayed during infection. Small-scale studies have reported minor changes in the self peptidome displayed by HLA-A*02;01 and HLA-B*07;02 after human immunodeficiency virus (HIV [20] ), influenza virus (INV [21] ), and measles virus (MeV [22] ) infections. Herein, we use a large-scale proteomics approach to study the dynamics of self peptides presented by five major HLA class I molecules, HLA-A*01;01, HLA-A*02;01, HLA-B*07;02, HLA-B*35;01, and HLA-B*45;01 before and after vaccinia virus (VACV) infection. In contrast to earlier studies (18) (19) (20) , we observed a profound shift in the self peptidomes uniquely displayed by the five HLA class I molecules studied herein after VACV infection. The newly presented self peptides did not derive from any specific chromosomal region. A fraction (approximately 40%) of them represented peptides derived from type I interferon-induced genes-consistent with the activation of cellular antiviral pathways-but also included other unrelated peptides, suggesting a global change in cellular protein metabolism in response to infection. Furthermore, population analyses of self peptides presented after infection revealed that a significant number of peptides were derived from proteins containing allelic variation(s). The frequency (approximately 12%) of allelic variation was similar to the rate of complications reported for transplants between HLA-matched pairs [23, 24] . This changing repertoire may provide a possible mechanism for the initiation of allograft rejection or GVHD. Hence, sequencing of the transplant donor and recipient transcriptomes/proteomes could help uncover potential allopeptides that can complicate allograft outcomes [15, 16, [25] [26] [27] [28] [29] [30] [31] [32] .
Materials and methods

Viruses
The Western Reserve strain of VACV (ATCC, VR-119) was grown in and titrated with BSC-40 cells as previously described [33] .
Large-scale cell culture and VACV infection
Soluble HLA class I (sA1.1, sA2.1, sB7.2, sB35.1, and sB45.1) production and harvest were used as described previously [34] . Briefly, approximately 1 × 10 9 viable cells were inoculated with VACV (MOI 0.1). Supernatants containing approximately 0.3-4.2 mg/L sA1, sA2, sB7, sB35, or sB45 were collected at 24, 48, and 72 h post inoculation.
Isolation and fractionation of class I associated peptides
sA1, sA2, sB7, sB35, and sB45 were affinity purified using W6/32-bound protein A Sepharose (GE Healthcare). Class I associated peptide elution, separation, and reversedphase HPLC purification were all performed as previously described [35] .
MS sequencing of eluted peptides
Lyophilized fractions were resuspended in 0.1% formic acid and subjected to reversed-phase microcapillary LC-nanoESI-MS/MS analysis using an Agilent 1100 binary HPLC pump and a linear trap quadropole (LTQ) linear ion trap mass spectrometer 2.2 (Thermofisher). A fritless, microcapillary column (100-m inner diameter) was packed with 10 cm of 5-m C 18 reversed-phase material (Synergi 4u Hydro RP80a, Phenomenex) as previously described [36] . RPC-fractionated peptides were loaded onto the column equilibrated in buffer A (0.1% formic acid, 5% ACN) using an LC Packing's autosampler. Flow splitting was used to reduce the HPLC flow rate from 200 to 0.3 L/min as previously described [36, 37] . Peptides from the microcapillary column were eluted directly into the linear ion LTQ mass spectrometer equipped with a microelectrospray source (James Hill Instrument Service).
Peptides were eluted using a 60-min linear gradient from 0 to 60% buffer B (0.1% formic acid, 80% ACN) at a flow rate of 0.3 L/min. During the gradient, the eluted ions were analyzed by one full precursor MS scan (400-2000 m/z) followed by five MS/MS scans of the five most abundant ions detected in the precursor MS scan while operating under dynamic exclusion. Sixty-five percent of peaks were identified in replicate samples by this analysis. The program extractms2 was used to generate the peak list and identify +1 or multiply charged precursor ions from the native MS data file [38] . Tandem spectra were searched with no protease specificity using SEQUEST-PVM [39] [40] . For multiply charged precursor ions (z ࣙ+2), an independent search was performed on both the +2 and +3 mass of the parent ion. A weighted scoring matrix was used to select the most likely charge state of multiply charged precursor ions as previously described [41, 42] . SEQUEST search results were imported into Bioinformatic Graphical Comparative Analysis Tools (BIGCAT) and analyzed as previously described [33, 41] . Xcorr threshold of 1.5 for charge state 1, 2.0 for charge state 2, and 2.5 for charge state 3 and above was used to filter the peptides. This resulted in a false discovery rate (FDR) of 3.6%, which was calculated as the percentage of the number of peptide hits from the reversed database in the total number of peptides in the filtered list (FDR = number of reverse peptides/total number of peptides × 100).
Bioinformatics
Searches for publicly reported CD8 T-cell epitopes and potential epitopes identified by algorithms were conducted through the Immune Epitope Database (http://www.iedb.org/). Peptide conservation among other Orthopoxviridae members was performed using basic local alignment search tool (BLAST) search (NCBI). Self peptides were searched against the human proteome and nucleotide databases using the PAM30 matrix with the BLAST search program restricting the searches with the entrez criterion txid9606[orgn] to specify Homo sapiens. Genes encoding these peptide sequences were verified to be present in the HeLa genome by searching the translated HeLa Cell Genome Sequencing Studies (phs000640.v2.p1) database at the Database of Genotypes and Phenotypes (dbGaP), Bethesda, MD: National Center for Biotechnology Information, National Library of Medicine [43, 44] . Proteins were classified by functional class using the Panther Database version 9.0 [45, 46] . Innate immune responsive proteins were identified using the Interferome database [47] . So also, self peptides derived from known or potential oncogenes products were identified by BLAST search against the TSGene database [48] . Tissue expression of proteins was determined using the Tissue-specific Gene Expression and Regulation (TiGER) database [49] .
Analysis
Microsoft Excel and PowerPoint, Prism GraphPad and Adobe
Photoshop were used to analyze data and generate graphs and figures.
Results
VACV infection induces a profound self peptidome shift
To determine whether the presentation of self peptides changes after VACV infection, which is known to alter host protein metabolism [50] [51] [52] [53] [54] [55] Comparative proteome searches identified 520 A*01;01-, 581 A*02;01-, 132 B*07;02-, 127 B*35;01-, and 303 B*45;01-associated VACV-derived peptides that were presented only upon infection; of those, 34 A*01;01-, 109 A*02;01-, 65 B*07;02-, 68 B*35;01-, 49 B*45;01-restricted peptide sequences correlated with the MS/MS spectra's fragment ion data with high confidence (see Section 2). Similar to prior reports, these naturally processed and presented peptides were derived from all functional and kinetic classes of VACV proteins (Table 1, Supporting Information Table 1 ; [33, 57] ).
To identify self peptides, MS/MS spectra of ligands eluted from the same class I preparation from which VACV peptides were identified were searched against a Human Ref However, since these peptides were eluted from HeLa cells, we ascertained whether the peptides identified by MS/MS analysis were contained within proteins encoded by the HeLa genome. For this, the HeLa Cell Genome Sequencing Studies database (phs000640.v2.p1; Database of Genotypes and Phenotypes [dbGaP], National Center for Biotechnology Information, National Library of Medicine [43, 44] ) was searched. Indeed, the peptide sequences reported herein were derived from proteins encoded by the HeLa genome (Table 2 and  Supporting Information Table 2 ).
In order to determine the reproducibility of peptide identification, peptides presented by HLA-A*02;01 were eluted from two independently infected cell samples and sequenced by MS/MS. Replicate analyses of the self peptides eluted from sA2.1 molecules expressed by VACV-infected cells revealed that approximately 60-80% of the HLA-bound peptides were presented at the same time points in both experiments (Supporting Information Table 3) .
Comparisons of the self peptides sequenced before and during infection revealed that all five HLA class I molecules investigated here presented numerous novel self peptide sequences after VACV infection. Ranging from approximately 30 to 80% of the sequenced peptides, we identified 965 A*01;01-associated (approximately 56%), 2783 A*02;01-associated (approximately 80%), 1025 B*07;02-associated (approximately 64%), 354 B*35;01-associated (approximately 35%), and 234 B*45;01-associated (approximately 30%) human peptide sequences that were presented solely after infection. Some of the new self peptides were presented stably throughout the course of the infection, while others (majority) were presented in a kinetic fashion: 1, 2, or 3 days post infection (Fig. 2) , likely reflecting the kinetics of protein expression from which a given peptide was derived. These data, in conjunction with the high reproducibility of the self peptides between replicate experiments, indicate that VACV infection induced a self peptidome shift that was much more profound than those induced by INV, MeV, and HIV infections [20] [21] [22] . 
Characterization of the self peptidome shift reveals that VACV infection upregulates type I IFN-regulated and other cellular pathways
We previously reported that about a fifth of the VACV peptides presented by HLA class I molecules were recognized during a natural infection [56] . We reasoned that the nonantigenic VACV peptides may have close sequence homology to the self peptides that are uniquely presented by infected cells. To narrow the analysis of these potentially homologous peptides, focus was laid on 169 A*01;01-, 309 A*02;01-, 157 B*07;02-, 71 B*35;01-, and 107 B*45;01-associated peptide sequences that correlated with the MS/MS spectra's fragment ion data with high confidence (see Section 2). These peptides were further interrogated to determine the mechanism(s) that induced the presentation of altered self peptidomes (Table 2 and Supporting Information Table 2 ). In initial analyses, self peptides were compared against the VACV proteome to determine whether self peptides uniquely presented after infection had similarity to VACV peptides. On average only about 4.7% (range 2.5-8.2%) of the self peptides were ࣙ66.6% identical, that is, less than three amino acid changes, when compared to potential VACV peptides (Table 2 and Supporting Information Table 2 ). Hence, there was very little sequence similarity between self and viral peptides presented after infection. The presentation of unique self peptides after infection had been reported to result from the activation of multiple cellular pathways [20, 22] . Therefore, we classified the proteins from which these unique infection-induced self peptides were derived based upon their cellular functions by searching the Panther database [45, 46] . This analysis revealed that the proteins, from which self peptides uniquely presented after infection were derived, were distributed among multiple functional categories (Fig. 3 and Supporting Information Table 2 ). There was little alteration in the proportion of each functional protein family after VACV infection compared with uninfected samples (Supporting Information Fig. 1 ), suggesting that no particular functional family was induced in response to infection. HeLa cells respond to infection with a type I interferon response by upregulating internal innate sensors and mediators to defend against infection [58] . Therefore, we specifically sought to identify whether interferon responsive proteins were upregulated following VACV infection by searching the Interferome database for proteins known to be responsive to type I interferons [47] . Approximately, 40% of the self peptides uniquely presented after infection were attributed to type I interferon signaling (Table 2 and Supporting Information Table 2 ). Hence, the remaining 60% of the newly presented peptides were derived from host proteins other than those directly responsive to interferon signaling (Fig. 3) . These proteins are either uniquely expressed post infection or are differentially processed by interferon-induced immunoproteasome in infected cells-compared to the standard proteasomes of uninfected controls. Therefore, alterations in host cell metabolism, possibly through interferon signaling, might play a significant role in the presentation of an infection-induced self peptidome.
Recent drafts of the human proteome revealed that proteins routinely expressed by cells were encoded by genes distributed across all chromosomes, but rarely, if at all, from chromosome 21 and not at all from the Y chromosome [25, 26] . Because our analyses so far indicated very little preference for protein families from which the infection-induced self peptides are derived, we mapped the chromosomal location of the genes that encode proteins from which newly presented peptides were derived in order to identify a particular chromosomal region containing the majority of newly presented peptides. The control of this region would perhaps point to a possible mechanism for this presentation. Infection-induced self peptides identified herein were derived from proteins encoded by genes distributed across all chromosomes with no concerted enrichment evident at any particular region of the human genome (gray bars, Fig. 4 and Supporting Information Fig. 2 ). Similar to the reported proteome maps, only a few peptides were derived from proteins encoded from chromosome 21, and from chromosomes 20 The number of proteins, from which peptides presented only after infection were derived, is enumerated for HLA-B*35;01 (gray bars). Due to size limitations, the locations of each peptide were grouped according to major banding patterns for each chromosome (e.g., 1p36) along the vertical axis (as in [26] ). Note the scale of the x-axis varies for each chromosome. The number of proteins containing allopeptides in the human population is enumerated for each location (red bars). and 22 as well. No proteins were identified as encoded from the Y chromosome; this is, consistent with the source HeLa cells being derived from a female subject [59] . Collectively, these data suggested that the shift in self peptide presentation by HLA class I molecules post VACV infection represented a global change in the overall protein metabolism of the cell and not a specific response to the infection.
Several peptides uniquely presented after infection are derived from oncogenes
Proteomics and proteogenomics approaches have recently identified a few neoepitopes derived from tumor-specific antigens [56, [60] [61] [62] [63] [64] . The success of these approaches was predicated on the knowledge of the tumor "mutome"-a collection of mutations within the tumor cell under study-encoded by nonsynonymous single nucleotide polymorphisms revealed by exome and/or transcriptome analyses [57, [60] [61] [62] [63] [64] . As HeLa cells were originally isolated from a cervical tumor, we determined whether the collection of self peptides presented by the five HLA class I molecules under study here were derived from the HeLa "mutome." Therefore, the proteins from which self peptides were derived were searched against the TSGene Database containing 184 tumor samples, including 28 cervical cancers [48] . On average, approximately 10% of self peptides were derived from proteins that are known or potential oncogenes (Table 2 and Supporting Information  Table 2 ). Self peptides derived from known oncogene products or candidate cancer proteins were then searched against the TSGene Database using BLAST to specifically identify self peptides that matched the mutated cancer protein sequence. We identified 16 HLA-A*01;01-, 34 HLA-A*02;01-, 13 HLA-B*07;02-, 22 HLA-B*35;01-, and 3 HLA-B*45;01-restricted self peptide sequences that match known cancer associated mutations (* in Table 2 and Supporting Information Table 2). Hence, a direct analysis of the five self peptidomes revealed that a fraction of the self peptides presented by class I molecules were derived from HeLa mutome.
Self peptidome presented after infection contains allopeptides
T-cell activation by peptides induced for presentation under inflammatory conditions may be of great significance for HLA-matched transplant recipients responding to infections. In this regard, it is noteworthy that immunosuppressed transplant recipients are susceptible to cytomegalovirus infections [65] [66] [67] [68] . This infection is known to induce acute allograft rejection [67, 68] and GVHD [65, 66] . These adverse outcomes would be further augmented if new peptides presented during infection contained allelic differences between the donor and recipient tissues as in allopeptides. Hence, recipient T cells would not be tolerized to such allopeptides. Therefore, in order to determine whether the self peptidomes presented after infection contains allopeptides, BLAST searches of the peptide sequences were performed against translated sequences from 297 human genomes. This analysis revealed variations of one to two amino acids in approximately 12% (range 9.6-13.2%) of the peptides newly presented after infection (Table 3; Supporting Information Table 4 ; red bars in Fig. 4 and Supporting Information Fig. 2 ). This percentage is well above the FDR calculated and presented in Section 2, suggesting the observed variability may be biologically relevant. In comparison, only about 2.7% (range 2.3-3.4%) of the self peptides presented before infection displayed variation among the human population. This is less than the FDR, suggesting that the presentation of allopeptides in uninfected cells may be an artifact of incorrect peptide identification. The percentage of allopeptides presented after infection (12%) is similar to previous reports of variations in human MHC class I associated peptides arising from genetic polymorphisms in the population [69] . We noted that the frequency of allopeptides (12%) was similar to the reported rates of unsuccessful transplants (10%), suggesting a possible relationship between allopeptides and transplantation success. However, the presentation of allopeptides would only affect clinical outcomes if those peptides are presented by cells in transplanted tissues. Search of the TiGER tissue expression database revealed that 75% of the proteins from which the allopeptides were derived are expressed at variable levels in commonly transplanted tissues such as the liver, heart, lung, kidney, and colon ( [49] ; Fig. 5 and Supporting Information Fig. 3 ).
Discussion
Cumulatively, we have shown a profound shift in self peptides presented by MHC class I molecules after infection of HeLa cells with VACV. Depending on the HLA allele, the new self peptides represented between 30 and 80% of all peptides presented during infection. They were derived from proteins Proteins expressed by the colon, heart, kidney, liver, and lungs were identified by searching the TiGER database of tissue expression. This database consists of expression data from microarray, real-time PCR, and proteomic studies and is reported as a fold change compared with housekeeping genes/proteins used in each respective assay. These proteins are variably expressed in the tissue; yet, all tissues express some proteins from which new peptides were derived after infection.
encoded by genes belonging to multiple cellular functional families and were broadly distributed across chromosomes. We did note that approximately 40% of the proteins from which peptides were derived were responsive to type I interferon signaling, which may play at least some role in the generation of these peptides uniquely presented after infection. Critically, a subset of the altered peptides contained allelic variations within the human population and the proteins from which they were derived were expressed in commonly transplanted tissues, suggesting the potential to negatively affect the outcome of clinical tissue/organ allografts.
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In addition to virus-induced changes in host cell metabolism, 40% of peptides uniquely presented after infection were derived from proteins responsive to host interferon signaling. Although not as effective as type II interferon, type I interferons have also been reported to induce immunoproteasomes [93] [94] [95] [96] [97] [98] [99] [100] , which in turn alters the processing of self and viral peptides for presentation by MHC class I molecules [101] . In response to both types I and II interferon signaling, the metabolism of HeLa cells is altered [102] [103] [104] [105] [106] [107] [108] [109] . Although it remains unknown whether VACV infection leads to upregulation and function of immunoproteasomes, the presentation of newly processed peptides represents a change in intracellular protein turnover that will include antigen processing by the immunoproteasome. It is also possible that the extent of self peptidome shift might vary between different viral infections and, if so, the mechanism underlying this process could be of interest for future studies. For example, whether levels of cellular interferon response correlate with the magnitude of the self peptidome shift for different classes of viruses.
In recent years, much attention has been directed to the production of unique peptides through alternate translation pathways [110] [111] [112] [113] [114] [115] [116] [117] . These cryptic peptides are produced from translation of alternate reading frames [118] [119] [120] [121] [122] , readthrough into the untranslated region [123] , and frame shift mutations [124] [125] [126] . The peptides uniquely presented during VACV infection reported herein map to protein coding regions; however, it is possible that these proteins are generated through these alternate translation mechanisms. Determining whether such peptides are generated by translation of alternate reading frames or through mutations occurring during translation will require further analyses as infection [114, 115, 120] and perhaps interferon signaling may accentuate this process.
Infection of HeLa cells was confirmed by the identification of VACV-derived peptides presented by all HLA molecules studied. Viral peptides presented by HLA-A*02;01 and HLA-B*07;02 were shown previously to contain a subset of peptides that elicit protective immune responses in HLA class I transgenic mice [33] . With similar characterization, a subset of the HLA-A*01;01-, HLA-B*35;01-, and HLA-B*45;01-restricted peptides reported here may also represent CD8 T cell epitopes useful for the development of next-generation vaccines.
Examination of self peptides presented by the five different HLA class I molecules revealed that each HLA molecule had a different propensity to present an altered self peptidome after infection. The greatest variety of newly presented peptides was observed with HLA-A*02;01 with 80.7% of the total peptides sequenced presented only after infection. HLA-B*07;02 and HLA-A*01;01 had an intermediate shift in the peptidome with 64.4 and 56.6%, respectively, of total peptides presented only after infection. The presentation of unique self peptides after infection was less striking for HLA-B*35;01 (35.4%) and HLA-B*45;01 (31.2%). It remains to be determined whether this variability among HLA class I molecules to present a shifted peptide repertoire after infection has a biological consequence, for example, whether it correlates with the susceptibility to allograft rejection.
Biologically, the presentation of self peptides by MHC class I molecules annotates the internal state of the cell. Our data indicated that VACV infection profoundly impacted the cellular metabolism and, hence, the altered state of the cell. Significantly, a fraction of the self peptides presented by class I molecules were derived from HeLa mutome. This finding implies that the knowledge of the self peptidomes of noncancer and cancer cells from the same individual can reveal neoepitopes that can be targeted by tumor-specific T cells. Considering the finding that viral infections can alter the presentation of self peptides, cancer therapies based on oncolytic viruses can coax the tumor cell to display neoepitopes that are coded by genes induced by viral infections [127, 128] .
Of clinical concern is whether T cells recognize the peptides from the shifted self peptidome. Aire-regulated peptide expression in the thymus is thought to lead to the presentation of self peptides derived from proteins ordinarily not expressed by the thymus [129, 130] . However, if these peptides are presented only after infection and are not presented during T-cell development, self-reactive T cells may persist in the periphery. Following infection, T cells may be activated under an inflammatory environment causing additional immunopathology. Recognition of cross-reactive peptides seems to be dependent upon only selected amino acid residues that vary for each particular T cell receptor [131] . Similarities within five amino acids between self and foreign peptides are sufficient to induce cross-reactive T cells after infection, potentially resulting in autoimmunity [132] . Yet, identification of these peptides proves to be difficult, as no single immunologic property is able to computationally predict immunogenic peptides [56] .
Our results may help to explain the complication and approximately 10% failure rate of transplantation even among HLA-matched allograft recipients. Of the peptides that were identified to be uniquely presented after infection, approximately 12% displayed allelic variation among the human population. These potential allopeptides in transplanted tissues would remain innocuous until the recipient acquired an infection. The presentation of new peptides during the inflammatory conditions generated in response to infection may result in T-cell activation and recognition of these potential alloepitopes. Again, if certain HLA class I molecules are less likely to present novel peptides after infection, patients that express them would be less susceptible to GVHD or allograft rejection. Analysis of the proteomes of donor and recipient transplant patient may identify these allopeptides prior to committing to the organ transplant. Following the recent publication of drafts of the human proteome, these comparisons may become more commonplace, leading to better proteomic matches for organ transplants, preventing allopeptide presentation after infection, and ultimately more successful transplants [25] [26] [27] [28] . 
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